Replies to post #98169 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

That's 40% premium from the last close. I hope Elanco will not shelf AT-014, and finds a way to deliver it the markets after a full approval. At least, this program is listed on the "best-in-class" Aratana portfolio list.

[ignatiusrielly35]

Interesting. Maybe now PETX can afford to pay ADXS the $35m milestone when it comes due.

[oakrock]

What does that mean to you in terms of good or bad for ADXS?

[oakrock]

From Elanco conference call included ADXS promo....

"Lastly, AT-014. This canine osteosarcoma vaccine is a novel immunology approach developed using a vaccine platform delivery system from – licensed from Advaxis. It was granted conditional licensure by the USDA Center for Veterinary Biologics in December of 2017. In a clinical study of 18 own – client-owned dogs with osteosarcoma, the data suggest that vaccine may delay or prevent metastatic disease and may prolong overall survival in the patients."

[gajj]

James, do u know what they paid? PETX stock was in the $3s last i checked

[mypekeispooped]

AT-014 would appear to be in competent hands with Elanco. Good-sized company with a global footprint.